Cart
sales@molnova.com
Clevidipine
CAS No. 167221-71-8
Clevidipine( Clevidipine | Clevidipine butyrate | Cleviprex | 167221-71-8 | Clevelox | Rac-Clevidipine )
Catalog No. M12548 CAS No. 167221-71-8
A dihydropyridine L-type calcium channel blocker, highly selective for vascular and has little or no effect on myocardial contractility or cardiac conduction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 50 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | 124 | In Stock |
|
| 200MG | 223 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClevidipine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA dihydropyridine L-type calcium channel blocker, highly selective for vascular and has little or no effect on myocardial contractility or cardiac conduction.
-
DescriptionA dihydropyridine L-type calcium channel blocker, highly selective for vascular and has little or no effect on myocardial contractility or cardiac conduction; reduces mean arterial blood pressure by decreasing systemic vascular resistance.Hypertension Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsClevidipine | Clevidipine butyrate | Cleviprex | 167221-71-8 | Clevelox | Rac-Clevidipine
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorAChR|CalciumChannel
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number167221-71-8
-
Formula Weight456.3164
-
Molecular FormulaC21H23Cl2NO6
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
-
Chemical Name3,5-Pyridinedicarboxylic acid,4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schwieler JH, et al. J Cardiovasc Pharmacol. 1999 Aug;34(2):268-74.
2. Ericsson H, et al. Eur J Pharm Sci. 1999 Apr;8(1):29-37.
3. Huraux C, et al. Anesth Analg. 1997 Nov;85(5):1000-4.
molnova catalog
related products
-
DS16570511 B
DS16570511 is a novel, cell-permeable inhibitor targeting the mitochondrial calcium uniporter. It effectively blocks the increase in Ca2+ influx dependent on MCU or MICU1 .
-
Ned 19
Ned 19, a selective membrane-permeant non-competitive antagonist of NAADP, strongly inhibits tumor growth, vascularization, and lung metastases in mice.
-
TTA-Q6
TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.
